Medicure Stock Market Value
| MCUJF Stock | USD 0.58 0.12 17.14% |
| Symbol | Medicure |
Medicure 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medicure's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medicure.
| 09/24/2024 |
| 11/23/2024 |
If you would invest 0.00 in Medicure on September 24, 2024 and sell it all today you would earn a total of 0.00 from holding Medicure or generate 0.0% return on investment in Medicure over 60 days. Medicure is related to or competes with Rezolute, Tempest Therapeutics, Forte Biosciences, Dyadic International, DiaMedica Therapeutics, Silo Pharma, and Molecular Partners. Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapi... More
Medicure Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medicure's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medicure upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 30.38 | |||
| Value At Risk | (7.35) |
Medicure Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medicure's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medicure's standard deviation. In reality, there are many statistical measures that can use Medicure historical prices to predict the future Medicure's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.88) | |||
| Treynor Ratio | 7.27 |
Medicure Backtested Returns
Medicure has Sharpe Ratio of -0.11, which conveys that the firm had a -0.11% return per unit of risk over the last 3 months. Medicure exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medicure's Standard Deviation of 3.97, mean deviation of 1.53, and Risk Adjusted Performance of (0.04) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.0354, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Medicure are expected to decrease at a much lower rate. During the bear market, Medicure is likely to outperform the market. At this point, Medicure has a negative expected return of -0.43%. Please make sure to verify Medicure's information ratio and the relationship between the skewness and relative strength index , to decide if Medicure performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.08 |
Virtually no predictability
Medicure has virtually no predictability. Overlapping area represents the amount of predictability between Medicure time series from 24th of September 2024 to 24th of October 2024 and 24th of October 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medicure price movement. The serial correlation of 0.08 indicates that barely 8.0% of current Medicure price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.08 | |
| Spearman Rank Test | -0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Medicure lagged returns against current returns
Autocorrelation, which is Medicure pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medicure's pink sheet expected returns. We can calculate the autocorrelation of Medicure returns to help us make a trade decision. For example, suppose you find that Medicure has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Medicure regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medicure pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medicure pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medicure pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Medicure Lagged Returns
When evaluating Medicure's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medicure pink sheet have on its future price. Medicure autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medicure autocorrelation shows the relationship between Medicure pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Medicure.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Medicure Pink Sheet
Medicure financial ratios help investors to determine whether Medicure Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicure with respect to the benefits of owning Medicure security.